Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Bacillus Calmette-Guerin (Copenhagen sub-strain 1077) 8.0 10 to 26.0 10 viable units per mL Powder for injection (vial) and diluent (ampoule) Evans Medical Limited, Speke, Liverpool, England BCG Vaccine Intradermal Note: This provisional consent is valid for 2 years from the date of publication of this notice. Dated this 23rd day of April 1996. HUGH BABER, Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.